News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 09 - 17

Hong Kong's First Five-Year Plan Unveiled! The Healthy Greater Bay Area Ushers in a Golden Five Years | Efung Knowledge Planet

Full text: approx. 2,191 Chinese characters | Reading time: approx. 3 minutesOn September 16, John Lee, Chief Executive of the Hong Kong Special Administrative Region, announced the First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026–2030)(hereinafter referred to as the "Plan") at the Legislative Council meeting, and subsequently delivered his fifth Policy Address during his term.【1】This is the first five-year plan formulated since Hong Kong's return to the motherland.When explaining the relationship between the two docume...

浏览次数：8

查看详情>>

发布时间: 2026 - 09 - 15

Efung Hardcore Sharing | From Targeting Proteins to Targeting RNA: How AI is Unlocking the Druggable Space of the Transcriptome

Modern drug discovery is built on an implicit premise: drugs act on proteins. Whether small molecules or antibodies, the essence is to find a pocket or epitope on a disease-causing protein, then bind to it and inhibit it. This paradigm has supported the pharmaceutical industry for nearly a century, and it is now approaching its ceiling—only about 1.5% of the human genome encodes proteins, of which only about ten percent are disease-related, and fewer than 700 proteins have actually been targeted by approved drugs globally to date. The vast majority of remaining disease-causing proteins—transcr...

浏览次数：17

查看详情>>

发布时间: 2026 - 09 - 12

Bridging with Capital to Forge a New Global Biotech Paradigm | Dr. Jinqiao Zhu of Evident Partners Speaks at BIOHK 2026

From September 9 to 12, 2026, the 5th Hong Kong International Biotechnology Conference and Exhibition (BIOHK 2026) was held at the Hong Kong Convention and Exhibition Centre. This year’s theme is Kaleidoscope, symbolizing a panoramic view of the industry from diverse perspectives — which mirrors the current landscape of China’s innovative drug sector: policy frameworks, capital logic and technological paradigms are all undergoing a shift. What the industry needs now is no longer a simplistic narrative, but judgment capable of weathering market cycles. Dr. Jinqiao Zhu, Founder & Chairma...

浏览次数：13

查看详情>>

发布时间: 2026 - 09 - 10

Efung News | Real Biotechnology's Non-Camptothecin Toxin Debuts at CBI 2026, Breaking Through the ADC Drug Resistance Bottleneck

Recently, the CBI 2026 Biomedical Innovation Expo concluded in Suzhou, with an exhibition area of over 36,000 square meters and more than 20,000 participants gathered on site to jointly create a new industry ecosystem. The conference featured multiple parallel forums. At the ADC New Drug Discovery and Front-End Technology Innovation Forum, Dr. Dang Qun, President of Real Biotechnology, shared the company's latest achievements in overcoming ADC drug resistance with its novel non-camptothecin TOPO1 inhibitor platform.ImagePrecision therapeutic approaches represented by next-generation ADC dr...

浏览次数：12

查看详情>>